A fairness assessment of mobility-based COVID-19 case prediction models
Abdolmajid Erfani, Vanessa Frias-Martinez

TL;DR
This study evaluates the fairness of mobility-based COVID-19 prediction models, revealing biases that favor certain demographic groups and highlighting the need for more equitable data collection methods.
Contribution
It demonstrates the presence of demographic biases in existing mobility-based COVID-19 prediction models and emphasizes the importance of improving data sampling for equitable health predictions.
Findings
Models perform better in wealthy, urban, young, and non-black counties.
Biases are linked to less representative mobility data for marginalized groups.
Highlighting the need for improved data collection to ensure fairness.
Abstract
In light of the outbreak of COVID-19, analyzing and measuring human mobility has become increasingly important. A wide range of studies have explored spatiotemporal trends over time, examined associations with other variables, evaluated non-pharmacologic interventions (NPIs), and predicted or simulated COVID-19 spread using mobility data. Despite the benefits of publicly available mobility data, a key question remains unanswered: are models using mobility data performing equitably across demographic groups? We hypothesize that bias in the mobility data used to train the predictive models might lead to unfairly less accurate predictions for certain demographic groups. To test our hypothesis, we applied two mobility-based COVID infection prediction models at the county level in the United States using SafeGraph data, and correlated model performance with sociodemographic traits. Findings…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealth disparities and outcomes · Data-Driven Disease Surveillance · COVID-19 epidemiological studies
